Anti-galBeta1-4glcnac epitope [6B4]

N. gonorrhoeae is a human adapted pathogen that infects the reproductive tracts of both male and females causing pelvic inflammatory disease (PID). In females, infection often goes undetected subsequently leading to issues with infertility

Contributors

Inventor Institute
Michael Apicella The University of Iowa
Cat. #: 153693
Unit size: 100 ug
Research Fields: Immunology;Microbiology
Target: lactosamine (galÎ?1-4glcnac) epitope found in lipooligosaccharide (LOS) of pathogenic Neisseria species
Reactivity: Neisseria sp.; Neisseria gonorrhoeae; Neisseria meningitidis
Clone: [6B4]
Host: Mouse
Class: Monoclonal
Product description: N. gonorrhoeae is a human adapted pathogen that infects the reproductive tracts of both male and females causing pelvic inflammatory disease (PID). In females, infection often goes undetected subsequently leading to issues with infertility
Conjugation: Unconjugated
Isotype: IgM kappa
Target background: N. gonorrhoeae is a human adapted pathogen that infects the reproductive tracts of both male and females causing pelvic inflammatory disease (PID). In females, infection often goes undetected subsequently leading to issues with infertility
Format: Liquid
Concentration: 1mg/ml
Storage buffer: PBS with 0.02% azide
Storage conditions: -15° C to -25° C
Shipping conditions: Dry ice
References:

Greiner et al. 2005. Infect Immun. 73(4):1964-70. PMID: 15784536.

Biofilm Formation by Neisseria gonorrhoeae.

Related Tools for Antibodies

Cat. # Tool Name
151022 Anti-IL12 [1-1A4] Key Info View Tool
151024 Anti-Hairy [1/24] Key Info View Tool
151031 Anti-RuvA [RuvA 12C6] Key Info View Tool
151034 Anti-HSVUL42 [13D11] Key Info View Tool
151018 Anti-Mos [R38.1] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.